(Press-News.org) SAN ANTONIO, Texas, U.S.A. (March 30, 2015) -- Patients with chronic kidney disease may be treated with a class of medications called Renin Angiotensin Aldosterone System inhibitors (RAASI's). Although these drugs protect the heart and kidney, a significant percentage of patients develop a dangerous side effect -- high potassium levels in the blood (hyperkalemia).
Elevated potassium puts patients at risk of death from cardiac arrhythmias. Lacking a drug to treat the problem, doctors either stop these beneficial drugs or may use kidney dialysis to quickly lower the potassium.
At the National Kidney Foundation Spring Clinical Meetings March 25-29 in Dallas, UT Medicine San Antonio renal specialist Wajeh Y. Qunibi, M.D., presented results from two national studies of ZS-9, a new oral drug that has been tested in more than 1,000 patients with high blood potassium.
The results are in a subgroup of patients with chronic kidney disease treated with RAASI's.
Dr. Qunibi is professor of medicine in the School of Medicine at The University of Texas Health Science Center at San Antonio.
The studies evaluated the effectiveness and safety of ZS-9.
"Dialysis is logistically difficult for patients, requires a catheter and is expensive," Dr. Qunibi said. "In our studies, patients took a dose by mouth three times daily with meals, and potassium normalized in 98 percent of them within 48 hours.
"This is a major change in the way to treat hyperkalemia."
He said between 5 percent and 30 percent of patients, depending on the type and stage of chronic kidney disease and whether they are treated with one or more RAASI's, may develop this high potassium condition.
It is estimated that more than 20 million people in the U.S. have chronic kidney disease in varying levels of severity. Risk increases with age, and the disease is most common in adults over 70, particularly those with diabetes.
Results of the ZS-9 studies were reported in recent months in the New England Journal of Medicine and the Journal of the American Medical Association.
INFORMATION:
For current news from the UT Health Science Center San Antonio, please visit our news release website, like us on Facebook or follow us on Twitter.
UT Medicine San Antonio is the clinical practice of the School of Medicine at the UT Health Science Center San Antonio. With more than 700 doctors - all School of Medicine faculty - UT Medicine is the largest medical practice in Central and South Texas. Expertise is in more than 100 medical specialties and subspecialties. Primary care doctors and specialists see patients in private practice at UT Medicine's flagship clinical home, the Medical Arts & Research Center (MARC), located at 8300 Floyd Curl Drive, San Antonio 78229. Most major health plans are accepted, and UT Medicine physicians also practice at several local and regional hospitals. Call (210) 450-9000 to schedule an appointment, or visit http://www.UTMedicine.org for a list of clinics and phone numbers.
If a lump is found in the breast of an adolescent girl, she often will undergo an excisional biopsy. However, breast cancer is rare in adolescents, and the vast majority of teenage breast lumps turn out to be benign masses that are related to hormones and often go away over time.
A recent Loyola University Health System study published in the Journal of Ultrasound in Medicine suggests that a breast ultrasound examination might eliminate the need for biopsy in many cases.
Loyola radiologists studied 37 teen girls with a total of 45 breast lumps to determine whether ...
The DNA molecule is chemically unstable giving rise to DNA lesions of different nature. That is why DNA damage detection, signaling and repair, collectively known as the DNA damage response, are needed. The DNA damage response is immensely important, for example, for ensuring the highest possible quality of the DNA before replication - duplication of the DNA prior to cell division. If the damaged DNA is replicated, the risk of cancer and other diseases increases significantly due to mutations. All in all this may lead to the death of a cell itself.
DNA repair consists ...
Fasting in combination with chemotherapy has already been shown to kill cancer cells, but a pair of new studies in mice suggests that a less-toxic class of drugs combined with fasting may kill breast, colorectal and lung cancer cells equally well.
If shown to work in humans, this combination could replace chemotherapy and make fasting a potent component of a long-term strategy to treat cancer, according to senior author Valter Longo of USC.
Human clinical trials in the United States and Europe are already studying the effectiveness and safety of Longo's strategy of ...
TORONTO, March 30, 2015 - In their latest brain imaging study on women at risk for Alzheimer's disease, York University researchers have found deterioration in the pathways that serve to communicate signals between different brain regions needed for performing everyday activities such as driving a car or using a computer.
"We observed a relationship between the levels of deterioration in the brain wiring and their performance on our task that required simultaneous thinking and moving; what we see here is a result of communication failure," explains Professor Lauren Sergio ...
March 30, 2015 - New estimates suggest that 20 to 30 percent of opioid analgesic drugs prescribed for chronic pain are misused, while the rate of opioid addiction is approximately 10 percent, reports a study in the April issue of END ...
New guidelines from the Canadian Task Force on Preventive Health Care to help prevent and manage obesity in children and youth recommend regular growth monitoring at routine health care visits as well as a focus on family lifestyles and health behaviours. The guidelines, published in CMAJ (Canadian Medical Association Journal), are aimed at helping primary care practitioners address this major public health issue.
Growth monitoring includes measuring weight, height or length, calculating body mass index and plotting these according to age using the measures on the WHO ...
SAN FRANCISCO--Located in the Marmara Sea, major earthquakes along the North Anatolian Fault (NAF) system have repeatedly struck what is current-day Istanbul and the surrounding region, but determining the recurrence rate has proven difficult since the faults are offshore. Cores of marine sediment reveal an earthquake history of the Cinarcik Segment, a main branch of NAF, and suggest a seismic gap where the next earthquake is likely to rupture, as detailed in a new study published in the Bulletin of the Seismological Society of America (BSSA).
The area has experienced ...
Researchers have been fascinated for a long time by learning and memory formation, and many questions are still open. Bochum-based neuroscientists Prof Dr Denise Manahan-Vaughan and Dr Hardy Hagena have discovered a key building block for this complex process. A particular neurotransmitter receptor, namely the metabotropic glutamate receptor 5, is a switch for activating opposing forms of plasticity in the hippocampus, a brain region vital for memory forming. They reported in the current edition of "The Journal of Neuroscience".
Synapses between neurons process different ...
While the body of evidence for feeding recommendations for children continues to evolve, one constant remains: Children do not eat enough vegetables. In fact, more than 90% of young children fail to meet vegetable recommendations, and these patterns often persist into adolescence and adulthood, making it important to understand the factors involved in establishing feeding patterns in early childhood. Are children not eating their vegetables because of texture, lack of role modeling, negative sensory experience, delayed introduction, bitter taste, infrequent exposure, rejection ...
A new star rating system can help hockey players to know just how well each helmet on the market can protect them from suffering head injuries and concussions during the course of a season. The "Hockey STAR" (Summation of Tests for the Analysis of Risk) rating is an extension of a similar rating system developed for football helmets. It was developed by researchers from Virginia Tech in the US, led by Bethany Rowson, and reported on in Springer's journal Annals of Biomedical Engineering.
More ice hockey players suffer concussion while playing hockey than their counterparts ...
